News & Events

Learn about what's new with CMC Biologics

CMC Biologics Enters into Development and Manufacturing Agreement with Trellis BioScience

News

Development of Trellis’ monoclonal antibody (mAb) using CMC Biologics’ proprietary CHEF1® Expression Platform and Multi-column Continuous Chromatography (MCC) Technology

 

 

Follow Us
Join us on LinkedIn Follow us on Twitter